US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 19:28:41 Source：Global Grid news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Uber and Lyft say they'll stay in Minnesota after Legislature passes driver pay compromise
- Next：Company wins court ruling to continue development of Michigan factory serving EV industry
Related articles
- Pope trip to Luxembourg, Belgium confirmed for September, 2 weeks after challenging Asia visit
- In China, latest Minions movie gets a new ending that promotes rule of law
- Fin Affleck's close friendship with JLo's child Emme Maribel Munniz, 16
- I lifted 200kg weights two days before giving birth
- Yu Darvish extends scoreless innings streak to 25 in Padres' 9
- What REALLY happened the night of OJ Simpson and Kris Jenner allegedly hooked up in the hot tub
- Inside the Cold War
- Outrage as Tesla starts shipping $3,000 Cybertruck tent that looks nothing like as advertised
- Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
- Lazy or genius? It's the gadget that's becoming a must
- Celebrity birthdays for the week of May 26
- Tailoring, light layers and on
- Lazy or genius? It's the gadget that's becoming a must
- Travellers share snaps of the worst behaved flight passengers
- Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
- London restaurant transforms into Charlie and the Chocolate factory
- New Yorker gives hilarious reaction to being underwhelmed by solar eclipse
- Children addicted to tech including smartphones are more at risk of psychosis, study suggests
- Liverpool confirms Arne Slot as Jurgen Klopp's replacement
- I was uninvited to my best friend's wedding
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Global Grid news portal sitemap